Plain-English translation of NCT07720323 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The WINNER Study is testing a wearable device called the EmeTerm that uses gentle electrical stimulation on your wrist to help reduce nausea. The device has already been approved by the FDA for motion sickness and pregnancy-related nausea, and researchers now want to see if it helps people with chronic nausea that hasn't gone away for at least two months. You would wear the device for 12 weeks and track how you feel each day.
Chronic nausea is exhausting and can make eating and daily life very difficult, but treatment options are limited. Researchers want to find non-medication approaches that can safely help people feel better.
You likely qualify if…
You likely don't qualify if…
You will first spend two weeks recording your daily nausea and gastrointestinal symptoms to establish a baseline. Then you'll receive the EmeTerm device and wear it for 12 weeks while continuing to track your symptoms in daily diaries and complete weekly and monthly questionnaires. Researchers will compare how you feel during the 12 weeks of device use to how you felt during the initial two-week observation period.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
United States
Enrollment target
~120 participants
Started
February 2023
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
SUBHANKAR CHAKRABORTY, M.D., Ph.D.
Ohio State University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.